database program openclinica open source software version 2.1 (OpenClinica LLC)
Structured Review
Database Program Openclinica Open Source Software Version 2.1, supplied by OpenClinica LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/open-source+database+and+software/openclinica+version+2+1/pm38923596-63-11-13
Average 90 stars, based on 1 article reviews
Images
Related Articles
other:Article Title: Evaluation of the safety and efficacy of dihydroartemisinin–piperaquine for intermittent preventive treatment of malaria in HIV-infected pregnant women: protocol of a multicentre, two-arm, randomised, placebo-controlled, superiority clinical trial (MAMAH project) Article Snippet: Data will be double entered into the study database using the Article Title: Evaluation of the safety and efficacy of dihydroartemisinin–piperaquine for intermittent preventive treatment of malaria in HIV-infected pregnant women: protocol of a multicentre, two-arm, randomised, placebo-controlled, superiority clinical trial (MAMAH project) Article Snippet: Data will be double entered into the study database 327 using the Article Title: Evaluation of the safety and efficacy of dihydroartemisinin–piperaquine for intermittent preventive treatment of malaria in HIV-infected pregnant women: protocol of a multicentre, two-arm, randomised, placebo-controlled, superiority clinical trial (MAMAH project) Article Snippet: Data will be double entered into the study database 326 using the Article Title: Innovative Approaches to Clinical Data Management in Resource Limited Settings Using Open-Source Technologies Article Snippet: Article Title: Evaluation of the safety and efficacy of dihydroartemisinin–piperaquine for intermittent preventive treatment of malaria in HIV-infected pregnant women: protocol of a multicentre, two-arm, randomised, placebo-controlled, superiority clinical trial (MAMAH project) Article Snippet: Data is double 287 entered into the study database using the Software:Article Title: Subthreshold Nanosecond Laser Intervention in Intermediate Age-Related Macular Degeneration: Study Design and Baseline Characteristics of the Laser in Early Stages of Age-Related Macular Degeneration Study (Report Number 1). Article Snippet: Purpose: The Laser Intervention in Early Stages of Age-Related Macular Degeneration (LEAD) study is an investigation of the safety and efficacy of subthreshold nanosecond laser treatment to slow the progression of intermediate age-related macular degeneration (AMD).. This report presents the novel study design and baseline characteristics.. Design: Multicenter, double-masked, randomized controlled, medical device feasibility clinical trial. Article Title: Safety and efficacy of dihydroartemisinin–piperaquine for intermittent preventive treatment of malaria in pregnant women with HIV from Gabon and Mozambique: a randomised, double-blind, placebo-controlled trial Article Snippet: Barcelona Institute for Global Health, Hospital Clínic Universitat de Barcelona, Barcelona, Spain (R González PhD, A Figueroa-Romero MSc, L Stoeger MSc, S Sanz MSc, S Méndez MSc, M Piqueras PhD, C Menendez PhD); Centro de Investigação em Saúde de Manhiça, Manhiça, Mozambique (R González, T Nhampossa PhD, A Mendes MD, E Sevene PhD, F Saúte PhD, C Menendez); Consorcio de Investigación Biomédica en Red de Epidemiología y Salud Pública, Madrid, Spain (R González, A Figueroa-Romero, L Stoeger, S Sanz, C Menendez); Instituto Nacional de Saúde, Ministério de Saúde, Maputo, Mozambique (T Nhampossa); Centre de Recherches Médicales de Lambaréné, Lambaréné, Gabon (G Mombo-Ngoma PhD, M Esen PhD, R Zoleko-Manego PhD, B Lell PhD, L B Dimessa MD); Center for Tropical Medicine, Bernhard Nocht Institute for Tropical Medicine & I Dept of Medicine University Medical Center Hamburg-Eppendorf, Hamburg, Germany (G Mombo-Ngoma, J Mischlinger PhD, Safety and efficacy of dihydroartemisinin–piperaquine for intermittent preventive treatment of malaria in pregnant women with HIV from Gabon and Mozambique: a randomised, double-blind, placebo-controlled trial |

